ZetaGen Therapeutics Company

ZetaGen Therapeutics commercializes a small molecule-based osteoinductive platform technology to develop.
Technology: Cell therapy
Industry: Private, Small & Large Molecules
Headquarters: Syracuse, New York, United States
Founded Date: 2015-01-01
Employees Number: 1-10
Investors Number: 3
Total Funding: 14200360
Last Funding Date: 2023-02-06
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership